A new study has revealed that there was a significant drop in Human Papilloma Virus (HPV) 16 and 18 infections among young women following the administration of HPV vaccine.

It found that HPV 16 and 18 infections, responsible for cervical cancer, decreased by 86% in women within the age group 16 to 21 who were eligible for the vaccination between 2010 and 2016 as adolescents.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

This data, which indiciates that the vaccination programme can cause a significant reduction in cervical cancer cases in future, was published in the Journal of Infectious Diseases.

One of the most common forms of cancer found in women aged under 35, cervical cancer kills around 850 women per year.

Public Health England (PHE) head of Immunisations Mary Ramsay said: “These results are very promising and mean that in years to come we can expect to see significant decreases in cervical cancer, which is currently one of the biggest causes of cancer in women under 35.

“This study also reminds us how important it is to keep vaccination rates high to reduce the spread of this preventable infection.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.
“These results mean that in years to come we can expect to see significant decreases in cervical cancer, which is currently one of the biggest causes of cancer in women under 35.”

“I encourage all parents of girls aged 12 to 13 to make sure they take up the offer for this potentially life-saving vaccine.”

Since its launch in 2008, more than 80% people aged between 15 to 24 have been vaccinated under the HPV vaccination programme.

The programme has also resulted into a drop in genital wart diagnoses, which are caused by some low-risk strains of HPV.

Between 2009 and 2017, the number of genital wart diagnoses in sexual health clinics among girls and boys aged 15 to 17 dropped by 89% and by 70%, respectively.

Furthermore, the study reported substantial fall in the prevalence of HPV31, HPV33 and HPV45.